Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Payables (2018 - 2025)

Historic Payables for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $521.7 million.

  • AdaptHealth's Payables rose 2122.08% to $521.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $521.7 million, marking a year-over-year increase of 2122.08%. This contributed to the annual value of $438.0 million for FY2024, which is 1173.26% up from last year.
  • As of Q3 2025, AdaptHealth's Payables stood at $521.7 million, which was up 2122.08% from $477.2 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Payables ranged from a high of $521.7 million in Q3 2025 and a low of $305.9 million during Q1 2021
  • Its 5-year average for Payables is $377.0 million, with a median of $350.7 million in 2021.
  • Per our database at Business Quant, AdaptHealth's Payables soared by 14611.34% in 2021 and then plummeted by 1522.68% in 2024.
  • AdaptHealth's Payables (Quarter) stood at $358.4 million in 2021, then fell by 5.83% to $337.5 million in 2022, then grew by 16.15% to $392.0 million in 2023, then increased by 11.73% to $438.0 million in 2024, then grew by 19.11% to $521.7 million in 2025.
  • Its Payables was $521.7 million in Q3 2025, compared to $477.2 million in Q2 2025 and $421.2 million in Q1 2025.